Abstract

A manifestation of Alzheimer's disease is the presence of amyloid depositions in brains of afflicted individuals. A major component of these depositions is the amyloid beta-protein, which is a truncated form of the larger amyloid beta-protein precursor (APP). To investigate the regulation of APP gene expression, the APP promoter and selected deletions were placed 5' to the reporter gene chloramphenicol acetyltransferase. The promoter deletions were transfected into different cell lines that showed variant levels of endogenous APP transcripts. Transient transfection assays showed that 96 base pairs 5' to the transcriptional start site are sufficient for cell type-specific promoter activity. A nuclear factor that binds to this region in a sequence-specific manner was identified by mobility shift electrophoresis, DNase footprinting, and methylation interference. The DNase-protected region covers about 25 base pairs on both strands (position -31 to -55). Mutations within this domain revealed a sequence of 12 base pairs that is crucial for factor binding. This sequence overlaps with the consensus sequences for transcription factors AP-1 and AP-4. However, competition experiments suggest that the nuclear factor that binds to the APP promoter is distinct from both AP-1 and AP-4. Factor binding to the characterized recognition sequence is observed in nuclear extracts originating from human, mouse, and rat cells, suggesting a high degree of conservation.

Highlights

  • From the Departmentof Psychiatry and .I2 havwral Science, State University of NewYork, Stony Brook, New York 11794-8101

  • These observations illustrate the imporspecific manner was identified by mobility shift elec- tance of elucidating the mechanism of amyloid @protein precursor (APP) gene expression

  • TheAPP promoter mediates neuron-specific gene petition experiments suggest that the nuclear factor expression of a reportergene in transgenic mice

Read more

Summary

MATERIALS ANDMETHODS

Cell Cultures and Transfection-The cell lines PC-12 (rat, neuronal properties; ATCC CRL 1721),C2C12 (mouse, myogenic; ATCCCRL 1772), Y79 (human, retinoblastoma; ATCC HTB 181, H4 (human, glioma; ATCC HTB 148), C6 (rat, glioma; ATCCCCL 107), and. The supernatant addition, the chicken @-actinpromoter was cloned into the polyclon- was discarded, and the pellet was homogenized in a total volume of ing site of pCAT2bGAL as a reference promoter. In this control 18 ml of buffer A. CAT assays (Gorman, 1985) were performedwith cell extracts oligonucleotides were synthesized on an Applied Biosystems DNA adjusted to identical @-galactosidaseactivity and quantitatedby liquid synthesizer They were deblocked and gel-purified prior to labeling scintillation counting of the acetylated and nonacetylated forms of ~-threo-[dichloroacetyl-l-~~C]chloramphenic(Aolmersham Corp.), which were excised from thin layer chromatographyplates. Fragments were 5' end-labeled with [-y-32P]AT(PManiatis etal.,1989) and incubated for 10 min at room temperature

RESULTS
GGGCCGGATCAGCTGACTCGCCTGGCTCT WI'
Findings
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call